by Bob Wold | Apr 18, 2022 | News
One understudied condition for which small doses of psychedelic substances such as psilocybin may be beneficial is cluster headache. As founder and executive director of the advocacy group Clusterbusters, I have seen firsthand, as a patient and an activist, that,...
by Bob Wold | Jul 13, 2020 | Busters Blog
I wanted to comment on our decision to cancel our annual in-person event this September and change it over to a virtual event. We understand how disappointed everyone is that were expecting to attend. This has been our hardest decision to make and myself, the Board of...
by Bob Wold | Jun 14, 2019 | News
As many of you may have heard, last Thursday, June 6, 2019, was an historical day for our community. Emgality became the first ever FDA approved drug developed to prevent cluster headache. We couldn’t be more excited! In addition to having a new and much needed...
by Bob Wold | Jun 6, 2019 | Busters Blog
One of the major issues our community has had to deal with over the years in getting proper treatment has been the difficulty many of us have in getting a proper and timely diagnosis. Things have been getting better but there are still too many people waiting years...
by Bob Wold | Oct 19, 2018 | Busters Blog
There has been a lot of misinformation going on (as is often the case with social media) regarding medications and other issues. Yes there is a lot of misinformation out there and misinformation about, misinformation. Yes many myths get carried forward but if you look...
